Novo to launch mid-stage tests with new diabetes pill

By Ben Hirschler LONDON (Reuters) - Novo Nordisk is about to launch a mid-stage clinical study with a tablet version of a so-called GLP-1 medicine as it steps up the hunt for diabetes pills that can replace injections. The Phase II trial may start as early as next week and will involve approximately 600 patients, Chief Science Officer Mads Krogsgaard Thomsen said on Thursday. "It is a milestone because this is not incremental innovation, it's disruptive innovation," he told Reuters in an interview during a visit to London. The Danish company is already the world's biggest supplier of diabetes medicines, which include its popular GLP-1 product Victoza.



via Health News Headlines - Yahoo! News http://news.yahoo.com/novo-launch-mid-stage-tests-diabetes-pill-174657792--finance.html